65,437 trials
Ureteral Calculi
Primary: Number of Participants With Stone Expulsion — 39; 40 Participants
Cardiac Rehabilitation
Primary: CR Adherence — 16.0; 14.4 Classes Attended
Asthma · Diabetes Mellitus
Primary: Annualized Rate of Change for Forced Expiratory Volume in 1 Second (FEV1) — -0.070; -0.035 L/yr
Idiopathic Thrombocytopenic Purpura · Thrombocytopenia · Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Primary: Number of Participants Utilizing Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Therapies for First-line Treatment — 128; 37; 3; 11 Participants
Type 1 Diabetes · Hypoglycemia · Metabolic Diseases
Primary: Composite Criteria: Insulin Independence and Glycosylated Hemoglobin (HbA1c) Under 6.5% at One Year — 71 Percentage of patients
Healthy
Primary: Cmax - Maximum Observed Plasma Concentration — 78.4; 78.2 ng/mL
Healthy Subjects · Sleep Initiation and Maintenance Disorders
Primary: Mean Tracking Error Assessed During the Continuous Tracking Test (CTT) — 10.29; 12.49; 13.48 pixels — p=0.267
Hereditary Angioedema (HAE)
Primary: Treatment Outcome Score at 4 Hours Post-Dose — 49.5; 18.5 units on a scale — p=0.037
Healthy
Primary: Cmax - Maximum Observed Plasma Concentration — 85.1; 83.0 ng/mL
Pain
Primary: The Percentage of Participants Achieving ≥30% Decrease From Baseline in Pain Intensity as Measured by WOMAC (Western Ontario and McMaster Universities Osteoarthritis…
Constipation
Primary: Percentage of Patients Having a Rescue-free Bowel Movement (RFBM) Within 4 Hours of the First Dose — 34.2; 9.9 percentage of participants — p=<0.001
Healthy
Primary: Cmax - Maximum Observed Plasma Concentration — 9.81; 9.58 ng/mL
HIV Infections
Primary: Number of Participants Who Achieved Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA) <50 Copies/mL at Week 48 — 241; 230 Participants
Psoriasis
Primary: Physician's Global Assessment (PGA) of Change Over Time (Good or Better) — 7; 0; 2; 9 participants
Non-small Cell Lung Cancer
Primary: Proportion of Subjects Surviving at One Year — 0.405 proportion